Hemogenyx Pharmaceuticals Plc (HEMO.L)

GBp 320.0

(-8.57%)

Total Assets Summary of Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc's latest annual total assets in 2023 was 6.1 Million GBP , down -13.91% from previous year.
Hemogenyx Pharmaceuticals Plc's latest quarterly total assets in 2024 Q2 was 6.11 Million GBP , down 0.0% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported annual total assets of 7.09 Million GBP in 2022, down -16.76% from previous year.
Hemogenyx Pharmaceuticals Plc reported annual total assets of 8.52 Million GBP in 2021, up 219.77% from previous year.
Hemogenyx Pharmaceuticals Plc reported quarterly total assets of 6.11 Million GBP for 2024 Q1, up 0.17% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported quarterly total assets of 7.22 Million GBP for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Historical Annual Total Assets of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Year	Total Assets	Total Assets Growth
2023	6.1 Million GBP	-13.91%
2022	7.09 Million GBP	-16.76%
2021	8.52 Million GBP	219.77%
2020	2.66 Million GBP	153.79%
2019	1.04 Million GBP	-54.34%
2018	2.29 Million GBP	-4.01%
2017	2.39 Million GBP	128.71%
2016	1.04 Million GBP	222.62%
2015	324.65 Thousand GBP	642.4%
2014	43.73 Thousand GBP	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	6.11 Million GBP	0.0%
2024 Q1	6.11 Million GBP	0.17%
2023 Q2	7.22 Million GBP	0.0%
2023 Q4	6.1 Million GBP	0.0%
2023 Q3	6.1 Million GBP	-15.48%
2023 FY	6.1 Million GBP	-13.91%
2023 Q1	7.22 Million GBP	1.85%
2022 Q1	7.84 Million GBP	-7.96%
2022 Q4	7.09 Million GBP	0.0%
2022 Q2	7.84 Million GBP	0.0%
2022 FY	7.09 Million GBP	-16.76%
2022 Q3	7.09 Million GBP	-9.56%
2021 FY	8.52 Million GBP	219.77%
2021 Q2	11.1 Million GBP	0.0%
2021 Q3	8.52 Million GBP	-23.28%
2021 Q4	8.52 Million GBP	0.0%
2021 Q1	11.1 Million GBP	316.82%
2020 Q3	2.66 Million GBP	-31.25%
2020 Q1	3.87 Million GBP	269.13%
2020 Q2	3.87 Million GBP	0.0%
2020 FY	2.66 Million GBP	153.79%
2020 Q4	2.66 Million GBP	0.0%
2019 Q1	1.55 Million GBP	-32.55%
2019 FY	1.04 Million GBP	-54.34%
2019 Q2	1.55 Million GBP	0.0%
2019 Q4	1.04 Million GBP	0.0%
2019 Q3	1.04 Million GBP	-32.31%
2018 Q2	1.88 Million GBP	0.0%
2018 Q1	1.88 Million GBP	-21.37%
2018 Q3	2.29 Million GBP	22.08%
2018 Q4	2.29 Million GBP	0.0%
2018 FY	2.29 Million GBP	-4.01%
2017 Q1	- GBP	-100.0%
2017 FY	2.39 Million GBP	128.71%
2017 Q2	941.93 Thousand GBP	0.0%
2017 Q3	2.39 Million GBP	154.32%
2017 Q4	2.39 Million GBP	0.0%
2016 FY	1.04 Million GBP	222.62%
2016 Q4	1.04 Million GBP	0.0%
2016 Q2	1.26 Million GBP	0.0%
2015 FY	324.65 Thousand GBP	642.4%
2014 FY	43.73 Thousand GBP	0.0%

Peer Total Assets Comparison of Hemogenyx Pharmaceuticals Plc

Name	Total Assets	Total Assets Difference